Lumbar Drainage of Intraventricular Hemorrhage
Launched by UNIVERSITY HOSPITAL HEIDELBERG · Jul 18, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment approach for patients who have experienced a specific type of brain bleeding called intraventricular hemorrhage (IVH), which can lead to dangerous swelling of the brain. The researchers want to find out if adding a procedure called lumbar drainage (which involves placing a drain in the lower back to help remove excess blood) to the standard treatment of an external ventricular drain (EVD) improves patient outcomes. The hope is that this combined approach can help patients recover better and possibly reduce the need for a more permanent solution like a ventriculoperitoneal (VP) shunt.
To participate in this trial, individuals must be at least 18 years old, have IVH with bleeding in certain parts of the brain, and be able to have the lumbar drain placed within 72 hours of their symptoms starting. It's important to note that those who have serious pre-existing health issues, are pregnant, or have a very limited life expectancy may not be eligible. Participants can expect to be closely monitored during the trial, and their progress will help researchers understand the benefits of this new approach to treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ICH with IVH (with hemorrhage in the 3rd and/or 4rth ventricle) with the need for EVD placement due to acute hydrocephalus
- • Age ≥ 18 y
- • Lumbar drain can be inserted within 72 h after symptom onset or patient last seen well
- Exclusion Criteria:
- • Premorbid mRS score \> 2
- • Pregnancy
- • Life expectancy \<6 months
- • Patient/family/caregiver unwilling or unlikely to opt for at least two weeks of aggressive therapy prior to consideration of transition to comfort measures/discontinuation of life support measures.
- • Treating physicians deeming the prognosis as so grave that an aggressive therapy is not warranted.
- • Other clear contraindication for treatment with a lumbar drain
About University Hospital Heidelberg
University Hospital Heidelberg is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a key player in translational medicine, the hospital integrates cutting-edge scientific discoveries with patient care, facilitating a robust environment for clinical trials. With a diverse range of specialties and a multidisciplinary approach, University Hospital Heidelberg aims to improve therapeutic outcomes and enhance the quality of life for patients through evidence-based practices. The institution is dedicated to fostering collaborations with academic partners, industry stakeholders, and regulatory bodies to drive forward-looking research initiatives and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Heidelberg, Baden Württemberg, Germany
Berlin, , Germany
München, Bayern, Germany
Heidelberg, , Germany
Patients applied
Trial Officials
Silvia Schönenberger, MD
Principal Investigator
Heidelberg University Hospital, Department of Neurology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported